Gene Expression Analysis of the Endocannabinoid System in Presymptomatic APP/PS1 Mice
Alzheimer's disease (AD) is the most common type of dementia and neurodegeneration. The actual cause of AD progression is still unknown and no curative treatment is available. Recently, findings in human samples and animal models pointed to the endocannabinoid system (ECS) as a promising therap...
Saved in:
Main Authors: | Laura Vidal-Palencia (Author), Carla Ramon-Duaso (Author), Jose Antonio González-Parra (Author), Arnau Busquets-Garcia (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Presymptomatic Diagnosis of Neurofibromatosis 2
by: J Gordon Millichap
Published: (1996) -
Gestation Related Gene Expression of the Endocannabinoid Pathway in Rat Placenta
by: Kanchan Vaswani, et al.
Published: (2015) -
Epigenetic mechanisms underlying the effects of triptolide and tripchlorolide on the expression of neuroligin-1 in the hippocampus of APP/PS1 transgenic mice
by: Xiaomei Lu, et al.
Published: (2019) -
Systematic Review of Presymptomatic Treatment for Spinal Muscular Atrophy
by: Katy Cooper, et al.
Published: (2024) -
Retrospective analysis of presymptomatic treatment in Sturge-Weber syndrome
by: Chelsea B. Valery, et al.
Published: (2024)